Press Release
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
November 14, 2022
Read More at Our Investor SiteWe do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Press Release
November 14, 2022
Read More at Our Investor SitePress Release
November 9, 2022
Read More at Our Investor SitePress Release
November 3, 2022
Read More at Our Investor Site